Association of CDH13 genotypes/haplotypes with circulating adiponectin levels, metabolic syndrome, and related metabolic phenotypes: The role of the suppression effect

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Teng, Ming Sheng ^a,b   Hsu, Lung An ^c   Wu, Semon ^b,d   Sun, Yu Chen ^e   Juan, Shu Hui ^a   Ko, Yu Lin ^b,f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Taipei Tzu Chi Hospital   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHINESE CULTURE UNIVERSITY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THYMINE; TRIACYLGLYCEROL; CADHERIN; CHOLESTEROL; H-CADHERIN; INSULIN;

ADULT; ARTICLE; CDH13 GENE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; INSULIN SENSITIVITY; INTRON; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHENOTYPE; POPULATION RESEARCH; PROMOTER REGION; TAIWANESE; TRIACYLGLYCEROL BLOOD LEVEL; ALLELE; BLOOD; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ADIPONECTIN; ADULT; ALLELES; CADHERINS; CHOLESTEROL; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLUCOSE; HAPLOTYPES; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 84929993431     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122664     Document Type: Article

References (38)

1. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003; 423:762-769. PMID: 12802337.
2. Matsuzawa Y, Funahashi T, Kihara S, himomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004; 24:29-33. PMID: 14551151.
3. Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C. Adiponectin: from obesity to cardiovascular disease. Obes Rev. 2009; 10:269-279. doi:10.1111/j.1467-789X.2009.00571.x PMID: 19389061.
4. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86:1930-1935. PMID: 11344187.
5. Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of adiponectin mutation with type 2 diabetes: A candidate gene for the insulin resistance syndrome. Diabetes. 2002; 51:2325-2328. PMID: 12086969.
6. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291:1730-1737. PMID: 15082700.
7. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA. 2009; 302:179-188. doi:10.1001/jama.2009.976PMID: 19584347.
8. Liu PH, Jiang YD, Chen WJ, Chang CC, Lee TC, Sun HS, et al. Genetic and environmental influences on adiponectin, leptin, and BMI among adolescents in Taiwan: A multivariate twin/sibling analysis. Twin Res Hum Genet. 2008; 11:495-504. doi:10.1375/twin.11.5.495 PMID: 18828732.
9. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes. 2007; 56(5):1198-209. PMID: 17303804.
10. Yang WS, Chuang LM. Human genetics of adiponectin in the metabolic syndrome. J Mol Med (Berl). 2006; 84(2):112-21. PMID: 16389553.
11. Cesari M, Narkiewicz K, De Toni R, Aldighieri E, Williams CJ, Rossi GP. Heritability of plasma adiponectin levels and body mass index in twins. J Clin Endocrinol Metab. 2007; 92:3082-3088. PMID: 17535986.
12. Henneman P, Aulchenko Y.S, Frants R.R, Zorkoltseva I.V, Zillikens M.C, Frolich M, et al. Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care. 2010; 33:908-913. doi:10.2337/dc09-1385 PMID: 20067957.
13. Jee SH, Sull JW, Lee JE, Shin C, Park J, Kimm H, et al. Adiponectin concentrations: A genome-wide association study. Am J Hum Genet. 2010; 87(4):545-52. doi:10.1016/j.ajhg.2010.09.004 PMID: 20887962.
14. Chung CM, Lin TH, Chen JW, Leu HB, Yang HC, Ho HY, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes. 2011; 60(9):2417-23. doi:10.2337/db10-1321 PMID: 21771975.
15. Gao H, Kim YM, Chen P, Igase M, Kawamoto R, Kim MK, et al. Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations. Diabetes. 2013; 62(12):4277-83. doi:10.2337/db13-0129 PMID: 24009259.
16. Wu Y, Gao H, Li H, Tabara Y, Nakatochi M, Chiu YF, et al. A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. Hum Mol Genet. 2014; 23(4):1108-19. doi:10.1093/hmg/ddt488 PMID: 24105470.
17. Hebbard LW, Garlatti M, Young LJ, Cardiff RD, Oshima RG, Ranscht B, et al. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res. 2008; 68(5):1407-16. doi:10.1158/0008-5472.CAN-07-2953 PMID: 18316604.
18. Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest. 2010; 120(12):4342-52. doi:10.1172/JCI43464 PMID: 21041950.
19. Morisaki H, Yamanaka I, Iwai N, Miyamoto Y, Kokubo Y, Okamura T, et al. CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat. 2012; 33(2):402-10. doi:10.1002/humu.21652PMID: 22065538.
20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 11: 2735-52.
21. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004; 27:1182- 6. PMID: 15111542.
22. Hsu LA, Ko YL, Wu S, Teng MS, Chou HH, Chang CJ, et al. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Metabolism. 2009; 58 (7):983-8. doi:10.1016/j.metabol.2009.02.021 PMID: 19394054.
23. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23:57-63. PMID: 10857969.
24. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000; 85: 2402-10. PMID: 10902785.
25. Teng MS, Hsu LA, Wu S, Chou HH, Chang CJ, Sun YZ, et al. Mediation analysis reveals a sex-dependent association between ABO gene variants and TG/HDL-C ratio that is suppressed by sE-selectin level. Atherosclerosis. 2013; 228(2):406-12. doi:10.1016/j.atherosclerosis.2013.03.032 PMID: 23623010.
26. Baron R, Kenny D. The moderator-mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. J Personality Soc Psychol. 1986; 51:1173-1182.33. PMID: 3806354.
27. MacKinnon DP. Analysis of mediating variables in prevention and intervention research. NIDA Res Monogr. 1994; 139: 127-153. PMID: 8742555.
28. Sobel ME. Direct and indirect effects in linear structural equation models. Sociol Methods Res. 1987; 15: 151-176.
29. MacKinnon D, Krull JL, Lockwood CM. Equivalence of the mediation, confounding and suppression effect. Prev Sci. 2000; 1: 173-181. PMID: 11523746.
30. Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociological Methodology. 1982; 13: 290-312.
31. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444(7121):881-7. PMID: 17167477.
32. de Luca C, Olefsky J.M. Inflammation and insulin resistance. FEBS Lett. 2008; 582(1):97-105. PMID: 18053812.
33. Aiello AE, Nguyen HO, Haan MN. C-reactive protein mediates the effect of apolipoprotein E on cytomegalovirus infection. J Infect Dis. 2008; 197(1):34-41. doi:10.1086/524144 PMID: 18171282.
34. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007; 13 (3):332-9. PMID: 17268472.
35. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000; 102(11):1296-301. PMID: 10982546.
36. Lee MH, Klein RL, El-Shewy HM, Luttrell DK, Luttrell LM. The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry. 2008; 47(44):11682-92. doi:10.1021/bi801451f PMID: 18842004.
37. Bauche IB, Ait El Mkadem S, Rezsohazy R, Funahashi T, Maeda N, Miranda LM, et al. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice. Biochem Biophys Res Commun. 2006; 345(4):1414-24. PMID: 16729974.
38. Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS, et al. Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome. Diabetologia. 2006; 49(11):2723-8. PMID: 17001470.